|
C11ORF82 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69869999955274E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.248120E-02 |
| Normal-vs-Stage2 |
3.931800E-02 |
| Normal-vs-Stage3 |
8.986100E-04 |
| Normal-vs-Stage4 |
3.162000E-02 |
| Stage1-vs-Stage2 |
6.256600E-01 |
| Stage1-vs-Stage3 |
5.716100E-03 |
| Stage1-vs-Stage4 |
3.927800E-02 |
| Stage2-vs-Stage3 |
8.173900E-02 |
| Stage2-vs-Stage4 |
1.822960E-01 |
| Stage3-vs-Stage4 |
8.707200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68798999999886E-05 |
| Normal-vs-AfricanAmerican |
7.800900E-03 |
| Normal-vs-Asian |
1.119210E-01 |
| Caucasian-vs-AfricanAmerican |
2.570000E-01 |
| Caucasian-vs-Asian |
2.620000E-01 |
| AfricanAmerican-vs-Asian |
2.326200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.51759999999346E-05 |
| Normal-vs-Female |
2.005400E-04 |
| Male-vs-Female |
1.997510E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.155730E-03 |
| Normal-vs-Extreme_Weight |
8.963100E-03 |
| Normal-vs-Obese |
1.601700E-03 |
| Normal-vs-Extreme_Obese |
3.212200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.438100E-02 |
| Normal_Weight-vs-Obese |
9.639800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.582900E-04 |
| Extreme_Weight-vs-Obese |
2.899600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.796810E-03 |
| Obese-vs-Extreme_Obese |
3.650000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.219640E-02 |
| Normal-vs-Age(41-60Yrs) |
1.55189999995198E-06 |
| Normal-vs-Age(61-80Yrs) |
2.737700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.816400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.435600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.019800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.080500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.057400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.167600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.741900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.555800E-03 |
| Normal-VS-Type2 PRCC |
4.764800E-04 |
| Normal-VS-KIRP CIMP |
5.424000E-03 |
| Normal-VS-Unclassified PRCC |
2.036000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.610000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.497100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.905500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.302390E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.528600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.370020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.519710E-03 |
| Normal-vs-N1 |
7.604800E-04 |
| Normal-vs-N2 |
1.858630E-01 |
| N0-vs-N1 |
5.984000E-03 |
| N0-vs-N2 |
1.716960E-01 |
| N1-vs-N2 |
4.593600E-01 |
|
|
